TRAV10 and COVID-19: Hospitalized COVID-19 and sepsis cases displayed reductions in the percentage of repertoire occupied by TRAV10, specific to invariant NK T cells, and TRAV1-2 and TRAJ33 usage, in keeping with reductions in MAIT cells (Figure S7H).